New drugs for malaria prevention (and the problems with the old ones)
Malaria is a parasitic disease causing 228 million clinical infections and 405,000 deaths annually in endemic countries1, and is a constant threat to travelers from other countries who lack any immunity to malaria. Despite a supply of artemisinin combination therapies and bed nets to treat malaria and prevent transmission, and a partially effective vaccine in the periphery, these tools alone are unlikely to allow regional malaria elimination in the near future.
In the travel medicine market, antimalarial drugs have been only partially adequate.They simply have not protected against all species of the parasite in all parts of the world. In addition, they have required busy travelers to adhere to daily dosing or complicated schedules for post-exposure prophylaxis. 60° Pharmaceuticals (60P) is proud to be providing new and better solutions.
The malaria threat – Prophylaxis
Reference 1.World Health Organization. Fact sheet: world malaria report 2019. Geneva, Switzerland: World Health Organization; 2019.